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Abstract 
Background: Approximately one‑third of stroke survivors suffer from post‑stroke depression (PSD) in the acute or 
chronic stages. The presence of PSD in the acute stage after stroke is reportedly associated with poor patient progno‑
sis; therefore, early recognition and treatment of PSD may alleviate these consequences. The aim of the current study 
was to examine the relationship between the lesion location and the presence of early depressive symptoms after 
acute ischemic stroke in Japanese patients.
Methods: Our study included 421 patients who suffered from acute ischemic stroke. On the day of admission, the 
lesion location was determined using magnetic resonance imaging (MRI). Stroke severity was measured on the sev‑
enth day of hospitalization withat the National Institutes of Health Stroke Scale (NIHSS). On the tenth day of hospitali‑
zation, depressive symptoms were measured and functional assessments were performed with the Japan Stroke Scale 
(Depression Scale) (JSS‑D) and functional independence measure (FIM), respectively.
Results: A total of 71 subjects (16.9 %) were diagnosed with depression. According to the multiple logistic regression 
analysis, the infarcts located at frontal and temporal lobes were found to be a significant independent risk factor of 
early depressive symptoms in the acute stage of stroke.
Conclusions: Patients suffering from acute ischemic stroke, particularly in the frontal and temporal lobes, should be 
carefully assessed to detect and treat early depressive symptoms; such treatment may improve patient outcomes.
© 2016 Metoki et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Post-stroke depression (PSD) is a serious neuropsychi-
atric complication with a high rate of prevalence after 
stroke. Approximately one-third of stroke survivors suf-
fer from early or late depressive symptoms after the 
onset of stroke [1]. Because PSD symptoms are related to 
increased functional disability [2] and poorer rehabilita-
tion outcomes [3], the factors associated with PSD are of 
great clinical importance.
Compared with patients who develop depressive 
symptoms later, patients who develop PSD during the 
acute stage of stroke demonstrate more somatic signs 
of depression rather than endogenous signs of depres-
sion [4], and they more frequently show early signs of 
melancholy, vegetative state, and psychological distur-
bance with poor social skills [5]. In addition, several lon-
gitudinal studies have shown that the incidence of PSD 
is higher in the first month post-stroke [6–8] compared 
with later in the first year after stroke. Although it is dif-
ficult to prevent stroke, the early screening and treatment 
of PSD in the acute stage may be the key to alleviating its 
long-term consequences.
In addition to psychological reactions due to disabil-
ity, loss of independence, and impaired quality of life 
(QOL) [9], pathophysiological factors, such as changes 
in neurotransmitters [10] and the specific site of infarcts 
[11], have also been hypothesized to be related to the 
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development of PSD. Indeed, the relationship between 
the stroke lesion locations and PSD has been the topic 
of much research [12]. Although many studies of PSD, 
including meta-analyses, have been reported, the asso-
ciation between the lesion location and the occurrence of 
PSD remains unclear [13–15], likely because of the vari-
ables, such as time post-stroke, and the type of instru-
ments used to assess PSD.
The objectives of this investigation were (1) to evalu-
ate the prevalence of early depressive symptoms among 
patients with acute ischemic stroke and (2) to examine 
the relationship between the lesion location and presence 
of early depressive symptoms. To our knowledge, this 
study is the largest to date in a Japanese population.
Methods
Participants
We reviewed the charts of 532 patients who were admit-
ted for acute stroke between April 2012 and March 2013 
at Hirosaki Stroke and Rehabilitation Center. The stroke 
diagnosis was based on both the presence of acute neu-
rological symptoms and a compatible lesion on magnetic 
resonance imaging (MRI) on the first day of hospitaliza-
tion. We excluded patients with (1) serious comprehen-
sion difficulties (e.g., severe aphasia), (2) hemorrhage, 
and (3) a history of psychiatric disease (e.g., depression, 
dementia, etc.). Psychiatric histories were obtained from 
medical records based on interviewing patients and 
family. After a detailed evaluation with inclusion and 
exclusion criteria, 421 patients who suffered from acute 
ischemic stroke participated in this study. The following 
information was collected for each patient: demograph-
ics (i.e., age, gender, education level, and living alone) and 
stroke severity, as measured with the National Institutes 
of Health Stroke Scale (NIHSS) on the seventh day of 
hospitalization [16]. Assessment of NIHSS scale was per-
formed by trained stroke nurses, and the testing was con-
firmed by neurologists.
The data collection for this study was approved by the 
Ethics Committee of the Hirosaki University School of 
Medicine and Hirosaki Stroke and Rehabilitation Center. 
Informed consent was obtained from all patients before 
the study.
Assessment of early depressive symptoms and functional 
independence
The Japan Stroke Scale (Depression Scale) (JSS-D), which 
was developed by the Japan Stroke Society, was admin-
istered to all participants to measure their depressive 
status [17]. The JSS-D is a 7-item (i.e., mood, guilt feel-
ings, interest, apathy, anxiety, sleeplessness, and expres-
sion) objective measurement, in which three choices are 
given for each item. The total score, which indicates the 
degree of depression, was calculated based on the proper 
weight of each choice. Based on ROC curve analysis of 
JSS-D, probable PSD was defined as a score of 2.4 or 
higher. The sensitivity and specificity of this cut-off score 
were 0.950 and 0.988, respectively [17]. In this study, 
JSS-D data were collected on the tenth day of hospitaliza-
tion to assess depressive symptoms in acute post-stroke 
phase (≤1 month). Assessment of JSS-D was performed 
by trained stroke nurses, and the testing was confirmed 
by psychiatrists.
Functional independence was assessed with the 
18-item functional independence measure (FIM), which 
consists of six domains: self-care, sphincter control, 
mobility, locomotion, communication, and social cogni-
tion. The FIM scores a patient’s dependence level from 18 
(total assistance in all areas) to 126 (complete independ-
ence in all areas) [18] and were administered on the tenth 
day of hospitalization. Assessment of FIM was performed 
by trained stroke nurses, and the testing was confirmed 
by neurologists.
Brain imaging
We performed MRI (Signa EXCITE HD 1.5T; GE Medi-
cal Systems, Waukesha, USA), including transversal 
diffusion weighted imaging (DWI), T2-weighted imag-
ing, and fluid-attenuated inversion recovery (FLAIR). In 
terms of the lesion classifications, information about the 
infarct site included the affected brain lobes (i.e., frontal, 
temporal, parietal, and occipital lobe) and the specific 
anatomical structure/location (i.e., thalamus, caudate, 
putamen, anterior and posterior limb of internal capsule, 
corona radiata, centrum semiovale, hippocampus, and 
amygdala). Stroke specialist physicians certified by Japan 
stroke society analyzed the images.
Statistical analysis
Descriptive analyses of the demographic and clinical 
variables were performed. To perform between-group 
comparisons of the main demographic and clinical char-
acteristics of the patients, an unpaired Student’s t test 
was performed to analyze continuous variables, and a 
Chi-squared test or Fisher’s exact test was performed to 
analyze categorical variables. Data are presented as the 
mean  ±  SD. All variables with p  <  0.10 in the univari-
ate analysis were subsequently analyzed by multivariate 
logistic regression. For confounding factors, including 
age, gender, education level, living alone, and NIHSS 
and FIM scores, multivariate logistic regression analysis 
was applied to assess the relationship between the lesion 
location and probable PSD, with a significance level of 
p < 0.05. Data were analyzed using the PASW Statistics 
PC software for Windows, version 18.0.0 (SPSS Inc., Chi-
cago, IL, USA).
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Results
Patient characteristics
The mean JSS-D score was 1.53  ±  1.62 for males and 
1.77  ±  2.24 for females (p  >  0.05). The prevalence of 
probable PSD (based on a JSS-D cut-off of 2.4) (17) was 
16.3 % in males (n = 43) and 17.8 % in females (n = 28) 
(p > 0.05). Table 1 shows the characteristics of the sub-
jects with and without depressive symptoms.
Logistic regression analysis
The lesion locations in patients with and without depres-
sive symptoms are shown in Table  2. The infarct more 
frequently affected the following locations in the prob-
able PSD group compared with the non-PSD group: the 
frontal lobe (p < 0.001), temporal lobe (p < 0.001), pari-
etal lobe (p  =  0.011), and putamen (p  =  0.011), when 
both sides were considered. To examine the potential 
independent radiological factors for the development 
of probable PSD, we included radiological findings with 
p < 0.10 from the univariate analysis in a multiple logistic 
regression model, which used adjusted factors including 
age, gender, and post-stroke NIHSS and FIM scores. This 
analysis suggested that independent radiological risk fac-
tors for probable PSD might include infarcts located at 
the frontal and temporal lobes (Table 3).
Discussion
In this study, the prevalence of PSD (based on the JSS-D 
score) was 16.9 % in the early stroke period. The preva-
lence of PSD in our study was within the range of previ-
ous results, ranging from 6 to 37 % [19–22]. This study of 
lesion locations demonstrated that frontal and temporal 
lobe area infarctions are significantly and independently 
associated with depressive symptoms at the tenth day of 
hospitalization.
In the 1980s, Robinson and colleagues [23] first showed 
that depression scores based on both Zung and Hamil-
ton rating scales were significantly higher in patients with 
left frontal lesions than in patients with lesions in any 
other location, indicating that there may be an associa-
tion between specific lesion locations and mood disorder 
in patients who suffered from acute stroke. Subsequently, 
several studies [24–27] have also shown that PSD was 
associated with lesions in the frontal lobes, basal gan-
glia, and temporal lobes. Recent studies have further 
demonstrated a relationship between the limbic-cortical-
striatal-pallidal-thalamic (LCSPT) circuit and the patho-
physiology of major depressive disorder [28, 29]. Terroni 
and colleagues have reported that among patients with 
ischemic stroke, larger lesions in the left cortical regions 
of the LCSPT circuit are associated with a higher inci-
dence of major depressive episode [30]. Together, these 
findings support our results and indicate that ischemic 
lesions in certain areas can increase the risk of PSD. 
However, our results concerning hemispheric lateraliza-
tion should be cautiously interpreted, because a recent 
meta-analysis observed that hemispheric laterality of 
ischemic lesions was not associated with the onset of 
PSD in an acute post-stroke subgroup [11].
To date, the depletion of biogenic amine neurotrans-
mitters or alterations in their post-synaptic receptor sen-
sitivities have been thought to play important roles in the 
development of PSD [10], and several studies have inves-
tigated medication for PSD [31, 32]. However, it should 
be noted that many PSD patients may not receive effec-
tive treatment for their mood disorders. To improve the 
long-term outcomes of stroke, it is important to provide 
early screening and treatment for PSD in the acute stage.
One strength of this study was the use of MRI to assess 
the infarct site. Many previous studies of PSD have used 
computed tomography (CT), whereas few studies in this 
field have used MRI. For detection of acute ischemic 
stroke, MRI provides greater image resolution, which can 
identify the site and extent of the infarct with more sensi-
tivity than CT [33, 34].
The current findings must be cautiously interpreted 
for the following reasons. First, this study used only one 
measure of depressive symptoms, the JSS-D, and patients 
Table 1 Characteristics according to subjects with and without depressive symptoms
PSD post-stroke depression, NIHSS National institutes of health stroke scale, FIM functional independence measure
Subjects with probable PSD Subjects without probable PSD p value
n 71 350






Amount of education (year) 9.9 ± 2.8 9.8 ± 2.5 0.936
Living alone 10 54 0.767
NIHSS total score 6.3 ± 5.2 2.7 ± 3.4 <0.001
FIM total score 72.7 ± 34.2 102.2 ± 28.4 <0.001
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were not diagnosed with clinical depression using the 
Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition. Although JSS-D screening has been well 
validated and is widely used to assess depressive symp-
toms, this tool is not a formal diagnostic tool for depres-
sion. In addition, the PSD assessment was conducted 
on the tenth day of hospitalization. Although half of 
the median reported prehospital delays ranging from 3 
to 4  h [35], we cannot completely rule out delays from 
onset to admission. Second, lesion size was not assessed 
in this study. Although some studies have not shown an 
association between lesion size and PSD [24, 36], other 
studies have reported that lesion size could affect the 









n % n %
Frontal lobe
 Any side 18 25.4 30 8.6 <0.001
 Left side 7 9.9 14 4.0 0.065
 Right side 11 15.5 16 4.6 <0.01
Temporal lobe
 Any side 18 25.4 28 8.0 <0.001
 Left side 7 9.9 12 3.4 0.027
 Right side 11 15.5 16 4.6 0.002
Parietal lobe
 Any side 18 25.4 47 13.4 0.011
 Left side 9 12.7 21 6.0 0.046
 Right side 10 14.1 33 9.4 0.238
Occipital lobe
 Any side 10 14.1 37 10.6 0.391
 Left side 3 4.2 16 4.6 1.000
 Right side 7 9.9 22 6.3 0.302
Thalamus
 Any side 6 8.5 42 12.0 0.391
 Left side 2 2.8 20 5.7 0.556
 Right side 4 5.6 24 6.9 1.000
Caudate
 Any side 6 8.5 13 3.7 0.109
 Left side 3 4.2 9 2.6 0.434
 Right side 3 4.2 4 1.1 0.097
Putamen
 Any side 18 25.4 47 13.4 0.011
 Left side 7 9.9 16 4.6 0.086
 Right side 11 15.5 31 8.9 0.089
Anterior limb of internal capsule
 Any side 6 8.5 13 3.7 0.109
 Left side 3 4.2 7 2.0 0.383
 Right side 3 4.2 6 1.7 0.181
Posterior limb of internal capsule
 Any side 6 8.5 33 9.4 0.796
 Left side 2 2.8 16 4.6 0.505
 Right side 4 5.6 17 4.9 0.766
Corona radiata
 Any side 23 32.4 111 31.7 0.911
 Left side 9 12.7 61 17.4 0.327
 Right side 14 19.7 50 14.3 0.245
Centrum semiovale
 Any side 12 16.9 47 13.4 0.442
 Left side 5 7.0 20 5.7 0.591
 Right side 7 9.9 28 8.0 0.605
Hippocampus










n % n %
 Left side 2 2.8 7 2.0 0.652
 Right side 2 2.8 8 2.3 0.679
Amygdala
 Any side 0 0.0 5 1.4 0.595
 Left side 0 0.0 1 0.3 1.000
 Right side 0 0.0 4 1.1 1.000
Table 3 Lesion locations associated with  having depres-
sive symptoms estimated by logistic regression analysis
Adjusted by age, gender, amount of education, living status, NIHSS, and FIM 
total score NIHSS National institutes of health stroke scale, FIM functional 
independence measure






 Any side 2.534 1.188–5.403 0.016
 Left side 1.849 0.607–5.636 0.279
 Right side 2.709 1.057–6.946 0.038
Temporal lobe
 Any side 3.082 1.454–6.535 0.003
 Left side 2.363 0.794–7.038 0.122
 Right side 3.093 1.212–7.895 0.018
Parietal lobe
 Any side 1.500 0.739–3.045 0.262
 Left side 2.201 0.871–5.565 0.095
Caudate
 Right side 6.936 1.328–36.237 0.022
Putamen
 Any side 1.933 0.956–3.908 0.067
 Left side 1.795 0.603–5.339 0.293
 Right side 1.803 0.782–4.156 0.166
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development of PSD [25, 37]. Third, some important 
factors, such as medical complications and medication, 
were not assessed by our study. Finally, we excluded sub-
jects with severe comprehension difficulties because they 
could not complete the evaluation, which could limit the 
generalization of our findings.
Conclusions
Our study found that the prevalence of PSD based on 
JSS-D was 17 %, which is in agreement with comparable 
studies. Patients who have suffered from ischemic stroke, 
particularly in the frontal and temporal lobes, should be 
carefully evaluated for early detection and treatment of 
depressive symptoms.
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